MedPath

Bicarbonate for AcidosiS in very pretErm babies: a randomised clinical trial: The BASE Trial

Phase 4
Conditions
Metabolic acidosis
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN18260410
Lead Sponsor
niversity of Oxford
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
3764
Inclusion Criteria

1. Babies born between 23+0 and 30+6 weeks+days of gestation inclusive
2. Postmenstrual age less than 34+0 weeks+days
3. Metabolic acidosis defined as blood pH less than 7.2 with pCO2 that is low or normal for the clinical context and a low bicarbonate level
4. The parent’s verbal consent for the baby to participate in the trial has been documented in the baby’s medical notes and Investigator Site File

Exclusion Criteria

1. Life-threatening condition, or significant congenital anomaly
2. Inborn error of metabolism (known or under active investigation)
3. Prior treatment with sodium bicarbonate unless in the context of cardiopulmonary resuscitation or if used as a substitute for normal saline in arterial line infusion.
4. Current episode of metabolic acidosis immediately follows cardiopulmonary resuscitation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath